arrow
C

Craig C. Hofmeister

winship cancer institute of emory university
H指数:56
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Accuracy of Real-Time PK-Guided Melphalan Dosing in Achieving Target Exposure in Myeloma Patients Undergoing Autologous Transplant

实时PK指导的美法仑剂量在实现多发性骨髓瘤自体移植患者目标暴露中的准确性

2026-07-290
OA
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study

Alnuctamab,一种靶向B细胞成熟抗原的双价T细胞结合剂,用于复发或难治性多发性骨髓瘤患者:一项1期首次人体研究的成果

Leukemia
IF13.4
2026-01-070
OAAI
Early CD4+Tcell proliferation and chronic Tcell engagement impact myeloma outcomes following Tcell engager therapy

早期CD4+ T细胞增殖爆发和慢性T细胞激活影响T细胞接合疗法后的骨髓瘤结局

2025-10-011
OA
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 Institutes

干细胞动员量与达鲁单抗(Dara)和来那度胺(Len)含药四联诱导疗法在 newly diagnosed multiple myeloma(NDMM)患者中的应用:2家机构真实世界经验

2025-04-110
PRE
Feasibility and Safety of Outpatient Model for Administration of Bispecific Antibodies: Proceedings from an International Myeloma Society 21st Annual Meeting Oral Abstract

双特异性抗体给药模式的门诊可行性与安全性:国际骨髓瘤学会第21届年会口头摘要

2025-04-080
OAAI
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at Two Institutes

干细胞动员量与达雷妥尤单抗(Dara)和来那度胺(Len)联合的四药联合诱导疗法在 newly diagnosed multiple myeloma(NDMM)患者中的真实世界经验:一项来自两家机构的观察研究

BLOOD
IF23.1
2024-11-050
PRE
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients

新诊断的骨髓瘤的四联疗法: 在符合移植条件的患者中,来那度胺,硼替佐米和地塞米松 (RVd) 与达拉图单抗联合RVD (DRVd) 的序贯疗法的比较分析

2024-09-130
OAAI
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy

多发性骨髓瘤和癌前病变中抗原特异性T细胞浸润和空间结构的调控

2023-08-0115
OAAI
Impaired SARS-CoV-2 Variant Neutralization and CD8+T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections
2022-12-1219
OA
REGULATION OF NEOANTIGEN SPECIFIC T CELL INFILTRATION AND SPATIAL TUMOR IMMUNE ARCHITECTURE OF MYELOMA AND ITS PREMALIGNANT PRECURSORS
2022-11-070
OA